BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15495180)

  • 1. A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy.
    Kattan MW; Giri D; Panageas KS; Hummer A; Cranor M; Van Zee KJ; Hudis CA; Norton L; Borgen PI; Tan LK
    Cancer; 2004 Dec; 101(11):2509-15. PubMed ID: 15495180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of axillary lymph node involvement of women with invasive breast carcinoma: a multivariate analysis.
    Olivotto IA; Jackson JS; Mates D; Andersen S; Davidson W; Bryce CJ; Ragaz J
    Cancer; 1998 Sep; 83(5):948-55. PubMed ID: 9731899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
    Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N
    Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
    Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of tumor size and lymph node status on breast carcinoma lethality.
    Michaelson JS; Silverstein M; Sgroi D; Cheongsiatmoy JA; Taghian A; Powell S; Hughes K; Comegno A; Tanabe KK; Smith B
    Cancer; 2003 Nov; 98(10):2133-43. PubMed ID: 14601082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma.
    Sun JM; Han W; Im SA; Kim TY; Park IA; Noh DY; Heo DS; Bang YJ; Choe KJ; Kim NK
    Cancer; 2004 Dec; 101(11):2516-22. PubMed ID: 15517588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of breast carcinoma in the elderly: implications for screening and treatment.
    Singh R; Hellman S; Heimann R
    Cancer; 2004 May; 100(9):1807-13. PubMed ID: 15112260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06.
    Deutsch M; Land SR; Begovic M; Wieand HS; Wolmark N; Fisher B
    Cancer; 2003 Oct; 98(7):1362-8. PubMed ID: 14508821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
    Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
    Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of searching for additional prognostic factors in combination with Nottingham Prognostic Index in breast carcinoma patients].
    Jakić-Razumović J; Corić M; Vrbanec D; Babić D; Hlupić L; Belev B
    Lijec Vjesn; 2005; 127(1-2):3-7. PubMed ID: 16145866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
    Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
    Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
    Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive model of axillary lymph node involvement in women with small invasive breast carcinoma: axillary metastases in breast carcinoma.
    Martin C; Cutuli B; Velten M
    Cancer; 2002 Jan; 94(2):314-22. PubMed ID: 11900217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A decision tool for predicting sentinel node accuracy from breast tumor size and grade.
    Coombs N; Chen W; Taylor R; Boyages J
    Breast J; 2007; 13(6):593-8. PubMed ID: 17983402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
    Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
    Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology?
    Mendez JE; Fey JV; Cody H; Borgen PI; Sclafani LM
    Ann Surg Oncol; 2005 Jan; 12(1):24-8. PubMed ID: 15827774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.